Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure-affinity relationships and molecular modeling studies

被引:43
|
作者
Catarzi, Daniela [1 ]
Colotta, Vittoria [1 ]
Varano, Flavia [1 ]
Poli, Daniela [1 ]
Squarcialupi, Lucia [1 ]
Filacchioni, Guido [1 ]
Varani, Katia [2 ]
Vincenzi, Fabrizio [2 ]
Borea, Pier Andrea [2 ]
Dal Ben, Diego [3 ]
Lambertucci, Catia [3 ]
Cristalli, Gloria [3 ]
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, Lab Progettaz Sintesi & Studio Eterocicli Biologi, I-50019 Sesto Fiorentino, FI, Italy
[2] Univ Ferrara, Dipartimento Med Clin & Sperimentale, Sez Farmacol, I-44100 Ferrara, Italy
[3] Univ Camerino, Sch Pharm, Med Chem Unit, I-62032 Camerino, MC, Italy
关键词
G protein-coupled receptors; Adenosine receptor antagonists; Pyrazoloquinazolines; Tricyclic heteroaromatic systems; Ligand-receptor modeling studies; FORCE-FIELD; PHARMACOLOGICAL EVALUATION; A(2A) RECEPTOR; CONFORMATIONAL ENERGIES; BIOLOGICAL EVALUATION; CRYSTAL-STRUCTURE; BINDING-ACTIVITY; POTENT; LIGAND; MMFF94;
D O I
10.1016/j.bmc.2012.10.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of 5-oxo-pyrazolo[1,5-c]quinazolines (series B-1), bearing at position-2 the claimed (hetero)aryl moiety (compounds 1-8) but also a carboxylate group (9-14), were designed as hA(3) AR antagonists. This study produced some interesting compounds endowed with good hA(3) receptor affinity and high selectivity, being totally inactive at all the other AR subtypes. In contrast, the corresponding 5-ammino derivatives (series B-2) do not bind or bind with very low affinity at the hA(3) AR, the only exception being the 5-N-benzoyl compound 19 that shows a hA(3) K-i value in the high mu-molar range. Evaluation of the synthetic intermediates led to the identification of some 5(3)-(2-aminophenyl)-3(5)-(hetero)arylpyrazoles 20-24 with modest affinity but high selectivity toward the hA(3) AR subtype. Molecular docking of the herein reported tricyclic and simplified derivatives was carried out to depict their hypothetical binding mode to our model of hA(3) receptor. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 50 条
  • [41] Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists:: Pyrazolo[1,5-α]pyrimidine derivatives
    Shiota, T
    Yamamori, T
    Sakai, K
    Kiyokawa, M
    Honma, T
    Ogawa, M
    Hayashi, K
    Ishizuka, N
    Matsumura, K
    Hara, M
    Fujimoto, M
    Kawabata, T
    Nakajima, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 928 - 938
  • [42] (5RS)-6H-Spiro[pyrazolo[1,5-c] quinazoline-5,4'-thiochroman]: efficient synthesis under mild conditions, molecular structure and supramolecular assembly
    Quiroga, Jairo
    Galvez, Jaime
    Cobo, Justo
    Glidewell, Christopher
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2015, 71 : 1028 - U314
  • [43] Synthetic studies on selective adenosine A2A receptor antagonists: Synthesis and structure-activity relationships of novel benzofuran derivatives
    Saku, Osamu
    Saki, Mayumi
    Kurokawa, Masako
    Ikeda, Ken
    Takizawa, Takuya
    Uesaka, Noriaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1090 - 1093
  • [44] Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists
    Baraldi, PG
    Cacciari, B
    Spalluto, G
    Bergonzoni, M
    Dionisotti, S
    Ongini, E
    Varani, K
    Borea, PA
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2126 - 2133
  • [45] Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands
    Okamura, T
    Kurogi, Y
    Hashimoto, K
    Nishikawa, H
    Nagao, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) : 2443 - 2446
  • [46] Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases
    Zheng, Danyang
    Yang, Chenqi
    Li, Xiaogang
    Liu, Dong
    Wang, Yan
    Wang, Xuesong
    Zhang, Xueying
    Tan, Yinfeng
    Zhang, Yuchen
    Li, Youbin
    Xu, Junyu
    MOLECULES, 2023, 28 (18):
  • [47] Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists.: Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations
    Pastorin, G
    Da Ros, T
    Bolcato, C
    Montopoli, C
    Moro, S
    Cacciari, B
    Baraldi, PG
    Varani, K
    Borea, PA
    Spalluto, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) : 1720 - 1729
  • [48] Pyrazolo-[1,5-a]-s-triazines as novel hCRF1 receptor antagonists:: Design, synthesis and structure activity relationships.
    He, LQ
    Gilligan, PJ
    Fitzgerald, L
    Zaczek, R
    Shen, H
    Trainor, GL
    Hartig, PR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1186 - U1186
  • [49] Design, facile synthesis, and evaluation of novel spiro- and pyrazolo [1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies
    Galvez, Jaime
    Polo, Stivens
    Insuasty, Braulio
    Gutierrez, Margarita
    Caceres, Daniela
    Alzate-Morales, Jans H.
    De-la-Torre, Pedro
    Quiroga, Jairo
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 74 : 218 - 229
  • [50] 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships
    Stefanachi, Angela
    Nicolotti, Orazio
    Leonetti, Francesco
    Cellamare, Saverio
    Campagna, Francesco
    Isabel Loza, Maria
    Manuel Brea, Jose
    Mazza, Fernando
    Gavuzzo, Enrico
    Carotti, Angelo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) : 9780 - 9789